Metraipolis › archive › dc_6fbfa05cda0c

Validated comprehensive RP HPLC approach for separation and quantification of solifenacin and mirabegron in the presence of their degradation products — Europe PMC PMID:41826414

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41826414
DOI
10.1038/s41598-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-11-04T10:42:29.943Z
SHA-256 of the archived text
70819652b32f10a79835e61c7630830805803eec29d339c6e21572830fb7e169
Stable URL of this page
https://metraipolis.com/documento/dc_6fbfa05cda0c

How to cite

Validated comprehensive RP HPLC approach for separation and quantification of solifenacin and mirabegron in the presence of their degradation products — Europe PMC PMID:41826414 — Europe PMC (en), https://europepmc.org/article/MED/41826414 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6fbfa05cda0c (Metraipolis archive dc_6fbfa05cda0c, sha256 70819652b32f10a79835e61c7630830805803eec29d339c6e21572830fb7e169)
BibTeX
@misc{dc6fbfa05cda0c,
  title = {Validated comprehensive RP HPLC approach for separation and quantification of solifenacin and mirabegron in the presence of their degradation products — Europe PMC PMID:41826414},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41826414},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6fbfa05cda0c; sha256 70819652b32f10a79835e61c7630830805803eec29d339c6e21572830fb7e169},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41826414. Agents can read the archived copy with the MCP tool read_document.